Videos

Experts discuss treatment for patients experiencing insomnia in conjunction with other health conditions.

Experts in attention-deficit/hyperactivity disorder (ADHD) discuss how to determine treatment failure in adults and the benefit of different dosing strategies for therapeutic options.

Drs Paul Doghramji and Leslie Citrome review prescription drugs and over-the-counter remedies for treating insomnia.

"I scribble as if my father is beside me years and years ago, scoring whole-notes, white holes through rims of night."

Vladimir Maletic, MD, MS, and Andrew Cutler, MD, highlight the use of long-acting injectables (LAIs) as a treatment option for bipolar 1 disorder.

Experts in psychiatry discuss the use of antipsychotics for treatment of bipolar 1 disorder.

How can psychiatrists help ease the fear surrounding elections?

How are these conditions connected, and what are the unique risks for athletes and military personnel?

Theresa Cerulli, MD, and Anthony Rostain, MD, MA, discuss challenges with substance abuse related to pharmacologic interventions for adult attention-deficit/hyperactivity disorder (ADHD) treatment.

Experts in treatment of attention-deficit/hyperactivity disorder discuss the benefits of different drug formulations and the potential for abuse of immediate-release medications.

Experts highlight cognitive behavioral therapy for insomnia (CBTI) and sleep hygiene as nonpharmacological approaches to the treatment of insomnia.

Drs Paul Doghramji and Leslie Citrome discuss daytime sleepiness and other symptoms of insomnia and their impact on quality of life.

"In the silence I could feel the air slip in and out of his lungs and the moment when the motion reversed, like a goldfish making the turn at the glass end of its tank..."

Andrew Cutler, MD, reviews the different types of medications for the management of bipolar I disorder.

Vladimir Maletic, MD, MS, and Andrew Cutler, MD, review FDA approved medications for the treatment of bipolar I disorder.

Are we like autumn leaves, psychologically preparing ourselves?

What makes a good friend? It takes work. Here's how you can share that with your patients.

Anthony Rostain, MD, MA, provides an overview of stimulants, nonstimulants, amphetamines, and methylphenidates for adult attention-deficit/hyperactivity disorder (ADHD) treatment.

Experts in attention-deficit/hyperactivity disorder (ADHD) discuss the importance of patient education and shared decision-making in working toward treatment goals.

Experts review the co-occurrence of insomnia with other medical conditions and discuss risks and triggers that lead to insomnia, such as age and psychiatric conditions.

Drs Paul Doghramji and Leslie Citrome provide an overview of the diagnosis and prevalence of insomnia.

Drs Stephen Faraone, Theresa Cerulli, Craig Chepke, and Andrew J. Cutler discuss novel drug delivery systems and provide take-home messages when treating an adult with ADHD.

Stephen Faraone, PhD; Theresa Cerulli, MD; Craig Chepke, MD, FAPA; and Andrew J. Cutler, MD, discuss implications of pharmacogenetic testing in ADHD.

"I was a Jewish boy from the Jersey burbs raised on corned beef and Milano cookies. She was a Mennonite farmgirl whose father shot deer for dinner."

In the final episode of this series, the experts share their conclusions and why examining the human side of fraud—in addition to the instruments of fraud—is key.

Experts in psychiatry discuss common comorbidities associated with bipolar I disorder, highlighting substance use disorders and anxiety.

Drs Vladimir Maletic and Andrew Cutler explore symptoms associated with bipolar I disorder, such as sensory acuity, recurrent depression, and manic episodes.

Do you know the Cowboy Creed?

Anthony Rostain, MD, MA, describes some of the signs and symptoms of adult attention-deficit/hyperactivity disorder (ADHD), as well as the impact on psychosocial skills.

Theresa Cerulli, MD, and Anthony Rostain, MD, MA, discuss the recent spike of adult attention-deficit/hyperactivity disorder (ADHD) diagnoses and how this has been impacted by COVID-19 and telehealth.